Impact of tortuosity of the V1-segment vertebral artery on mechanical thrombectomy Authors: Zhoucheng Kang, Hanghang Zhao, Dong Wei, Yang Li, Rui Shi, Li Li Published: 2024 ABSTRACT Tortuosity of the vasculature poses challenges to mechanical thrombectomy (MT); however, only a few studies have reported the impact of vertebral artery (VA) tortuosity on MT. The present study aimed to investigate the impact of tortuosity of the V1-segment VA on MT in patients with acute vertebrobasilar artery occlusion (AVBAO). The patients diagnosed with AVBAO and treated with MT in the Stroke Center of Xijing Hospital from November 2019 to March 2022 were analyzed retrospectively. According to the tortuosity of V1-segment VA, patients were divided into tortuous (coiling and kinking) and non-tortuous groups (straight, single-arc, and multi-arc). A binary logistic regression model was established to analyze the association between the tortuosity of V1-segment VA and successful reperfusion (mTICI ≥ 2b), neurological improvement at 7 days, favorable and poor outcome at 90 days, and symptomatic intracranial hemorrhage (ICH) within 24 h. After adjustment for age, baseline National Institute of health stroke scale (NIHSS) score and puncture-to-recanalization time, the impact of tortuosity of the V1-segment VA on outcomes was analyzed. After screening, 35 patients were enrolled in this study. The overall rate of successful reperfusion was 74.3% (26/35), and 40% (14/34) patients achieved favorable outcomes at 90 days. Subsequently, 15/35 (42.9%) patients were included in the tortuous group, and the remaining 20 patients comprised the non-tortuous group. After adjustment for age, baseline NIHSS score, and puncture-to-recanalization time, the rate of 90-day favorable outcome in the tortuous group was significantly lower than that of the non-tortuous group (20% vs. 57.9%, P = 0.034), while the rates of reperfusion (80% vs. 73.7%) and 7-day neurological improvement (33.3% vs. 36.8%) were similar between the two groups. The incidence of 24-h symptomatic ICH in the tortuous group was higher than that in the non-tortuous group (26.7% vs. 15.8%), albeit not significantly. In patients with AVBAO, tortuosity of the V1-segment VA was negatively associated with favorable outcomes 90 days after MT. Introduction Compared to acute anterior circulation occlusion, acute vertebrobasilar artery occlusion (AVBAO)-related ischemic stroke is associated with higher rates of disability and mortality1. Neither BEST2 nor BASICS3 demonstrated that patients with AVBAO would benefit from endovascular treatment (EVT). BASILAR4 is a multicenter prospective registry study, suggesting that EVT improves clinical outcomes. Despite the lack of high-grade medicine-based evidence, EVT has been widely carried out in clinical practice to assess the disastrous consequences for patients with AVBAO1. Until May 2022, BAOCHE5 study presented at the European Stroke Organization Conference (ESOC 2022) provided evidence-based proof for the posterior circulation EVT, showing that EVT significantly improved the 90-day clinical outcomes compared to the best medical treatment (46.4% vs. 24.3%). Although the technical success rate is about 85%, the benefit rate is only 32–44%.[3, 4 Several studies have shown that prolonged time of reperfusion is a major factor affecting the outcomes of EVT2,6; therefore, the recanalization of occluded vessels is the primary target of EVT. Tortuous vascular paths are the common causes of complications and even mechanical thrombectomy (MT) failure. The tortuous vascular anatomy hinders the smooth passage of microwires and microcatheters and prolongs the time of reperfusion7. In addition, during the pull-back process, the tortuous vessels may lead to the deformation and even collapse of the stent retrievers or aspiration catheters, which would reduce the combination power between the thrombectomy device and thrombosis and reduce the possibility of achieving the mTICI 2b/3 reperfusion8. Different from the MT of anterior circulation occlusion, bilateral vertebral arteries can be used as a path to the basilar artery for MT; however, up to 64% of patients with AVBAO have unilateral or bilateral extracranial vertebral artery (VA) stenosis or occlusion9, which greatly increases the difficulty of MT. Although the anatomic configuration of V1 segment of the VA has been classified previously10, the impact of tortuosity of the V1-segment VA on MT has only been studied by a few scholars11. This study retrospectively analyzed the patients with AVBAO undergoing MT in the Stroke Center of Xijing Hospital, aiming to investigate the association between the tortuosity of the V1-segment VA and outcomes of MT. Methods Study subjects Patients with AVBAO undergoing MT in the Stroke Center of Xijing Hospital from November 2019–March 2022 were enrolled in this study. The institutional review boards of Xijing Hospital approved the trials (KY20212150-C-1), and written informed consent was obtained from enrolled patients or their surrogates for endovascular treatment (EVT). All methods were performed in accordance with relevant guidelines and regulations. Written informed consent for registration was waived because the study was retrospective in nature and utilized anonymized data. Inclusion criteria: (1) ≥ 18-years-old; (2) acute occlusion of the basilar artery or the intracranial VA resulting in no forward flow to the basilar artery confirmed by digital subtraction angiography; (3) MT was performed within 24 h after onset. Exclusion criteria were as follows: (1) patients who underwent intracranial angioplasty or stenting at the same time; (2) patients with spontaneous recanalization or no occlusion of the basilar artery by angiography; (3) patients with tandem vertebrobasilar artery occlusion (extracranial VA recanalization or angioplasty must be performed before MT); (4) incomplete baseline data. (Fig. 1) Fig. 1Flow chart of this study participants. MT: mechanical thrombectomy, AVBAO: acute vertebrobasilar artery occlusion. Flow chart of this study participants. MT: mechanical thrombectomy, AVBAO: acute vertebrobasilar artery occlusion. Mechanical thrombectomy All patients were treated with local anesthesia and conscious sedation. Angiographic catheters were used to identify the vascular pathways and vertebrobasilar artery occlusion, and carotid angiography was used to assess collateral compensation. The MT procedure consisted of stent retriever thrombectomy, thrombus aspiration, or a combination of the two approaches. All patients in this study were treated with a 6 F guiding catheter (Johnson & Johnson, USA), and the catheter was placed in the V1-V2 segment. The aspiration catheters include Sofia (MicroVention, USA) and Catlyst (Stryker, USA), and the stent retrievers include Solitaire (EV3 USA) and Trevo XP Provue (Stryker). Typically, MT is performed less than three times. All endovascular procedures were performed by an experienced neurointervention team. The head computed tomography (CT) scan was performed immediately after MT. Baseline data collection The following data were collected: age, sex, medical history (hypertension, diabetes, coronary heart disease, atrial fibrillation, and previous stroke), smoking, drinking, stroke etiologic classification, onset to groin puncture time, admission to groin puncture time, groin puncture to recanalization time, neurological deficits, and intravenous thrombolysis. The National Institution of Health Stroke Scale (NIHSS)12 was used to assess the degree of neurological deficits. According to TOAST13 classification, the etiologies of stroke were classified into large artery atherosclerosis, cardiogenic embolism, and other etiologies. V1-segment vertebral artery tortuosity The morphology of the V1-segment VA was determined from the view of digital subtraction angiography (DSA). Classification of the V1-segment VA tortuosity was conducted independently by two experienced neurointerventionists. In case of disputes, another neurointerventionist was invited to review the radiographs and determine the classification. All the experts were blinded to clinical data. According to the classification of extracranial internal carotid artery (ICA) tortuosity14, the V1-segment VA was classified as follows: straight, single-arc tortuosity (single curve), multi-arc tortuosity (≥ 2 arcs, S-shaped curve or wave-shaped curve), coiled (folded VA forming arterial loop), and kinked (folded VA forming acute [< 90°] angulation) (Fig. 2). Fig. 2Classification of the V1-segment VA. The V1-segment VA was classified into five types as follows: straight, single-arc tortuosity (single curve), multi-arc tortuosity (≥ 2 arcs, S-shaped curve or wave-shaped curve), coiled (folded VA forming an arterial loop), and kinked (folded VA forming acute [< 90°] angulation). Classification of the V1-segment VA. The V1-segment VA was classified into five types as follows: straight, single-arc tortuosity (single curve), multi-arc tortuosity (≥ 2 arcs, S-shaped curve or wave-shaped curve), coiled (folded VA forming an arterial loop), and kinked (folded VA forming acute [< 90°] angulation). Previous studies have shown that when the folded VA forms an arterial loop or acute angulation, the hemodynamics of VA are significantly disordered10. Therefore, in this study, patients were divided into two groups (tortuous and non-tortuous) according to the tortuous degree of V1-segment VA. The tortuous group included patients with coiled or kinked VA, while other patients were included in the non-tortuous group. Outcomes The outcomes included successful reperfusion, post-stroke neurological improvement at 7 days, favorable outcomes and poor outcomes, and symptomatic ICH within 24 h post-operation. The modified thrombolysis in cerebral infarction (mTICI) scale was used to evaluate the reperfusion after MT, and successful reperfusion was defined as the achievement of mTICI score 2b/3.15 The neurological improvement was defined as a ≥ 10-point decrease of the NIHSS score from baseline or the score of 0 at 7 days from onset16. Head CT was used to evaluate the ICH within 24 h post-operation, including parenchymal hemorrhage and subarachnoid hemorrhage. Symptomatic ICH was defined as intracranial hemorrhage-associated neurological deterioration with ≥ 4-point increase in the NIHSS score17. The functional prognosis was evaluated by modified Rankin scale (mRS)18. At 90 days post-operation, the mRS scores were assessed by experienced neurologists by telephone or outpatient follow-up to evaluate the functional prognosis of the patients. The mRS scores of 0–2 and 5–6 were defined as favorable and poor outcomes, respectively16. Statistical analysis Herein, we compared the baseline characteristics, treatment profiles, and outcomes between the tortuous and the non-tortuous groups. Means ± standard deviations (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\stackrel{-}{X}\pm\:S)$$\end{document} were calculated for continuous variables with normal distribution, and t-test was used for comparison between groups. Median and quartiles [M (P25, P75)] were used for continuous skewed distribution, and Mann-Whitney U test was used for comparison between groups. Categorical parameters were presented as numbers and percentages, and chi-square test or Fisher’s exact test was performed for comparison between groups. Binary logistic regression models were established to analyze the statistical association between the tortuosity of the V1 segment VA and each outcome, and the odds ratios (OR) with 95% confidence intervals (CIs) were calculated for the tortuous group using the non-tortuosity group as the reference. After adjustment for age, baseline NIHSS score, and groin puncture to reperfusion time, the impact of tortuosity of the V1-segment VA on each outcome was analyzed. Cohen’s kappa coefficient was used to analyze the consistency of VA classification between the two experts. Two-sided P<0.05 was considered significant. Statistical analyses were carried out using the SPSS software package (version 25.0). Results Patients’ characteristics From November 2019–March 2022, a total of 35 patients (21 men [60%]; median age, 65 [52, 70] years; median NIHSS score, 18.5 [6.75, 32.75]) were included in this study. A total of 12 patients (34.3%) underwent intravenous thrombolysis (IVT) prior to MT. Ten patients (28.6%) were treated by thrombus aspiration, and 25 patients were treated by stent retriever combined with aspiration thrombectomy. Of the 35 patients, 18 (51.4%) had large artery atherosclerosis (LAA), 14 (40%) presented cardiogenic embolism, and the remaining 3 (8.6%) showed other etiologies. Successful reperfusion (final mTICI score ≥ 2b) was achieved in 26 patients (74.3%); the median time from groin puncture to reperfusion was 135 min (95,210). Comparison of baseline data between groups In the present study, Cohen’s Kappa coefficient was used to analyze the consistency of two experts’ evaluation of tortuosity of the V1-segment VA in 35 patients. Both experts agreed that 10 patients should be assigned to the tortuous group and 18 to the non-tortuous group. However, 3 patients were identified as a tortuous group by expert 1, but as non-tortuous group by expert 2; also, 4 patients were identified as a tortuous group by expert 2, but non-tortuous by expert 1. The overall Cohen’s kappa coefficient was 0.578 (P = 0.001), showing moderate consistency. The discussion was required for 7 cases; 5 were classified as the tortuous group and 2 as the non-tortuous group. Finally, 15 (42.9%) patients were included in the tortuous group, and the remaining 20 (57.1%) in the non-tortuous group. After stratification by group, the time from admission to groin puncture in the non-tortuous group was longer than that in the tortuous group (46 min vs. 32 min, P = 0.039). Notably, compared to the non-tortuous group, the tortuous group had a higher median age (68 years vs. 63 years), higher baseline NIHSS score (24.5 vs. 18), and longer time from groin puncture to reperfusion (165 min vs. 125 min), although the differences were not statistically significant. Factors, such as medical history, classification of etiology, thrombectomy method, and intravenous thrombolysis, were similar between groups (Table 1). Table 1Comparison of baseline characteristics between groups.All (n = 35)Tortuous group (n = 15)non-Tortuous group (n = 20) P Age, years65.0 (52.0, 70.0)68.0 (57.0, 74.0)63.0 (47.0, 67.0)0.067Men21 (60.0%)7 (46.7%)14 (70.0%)0.163Smoking13 (37.1%)6 (40.0%)7 (35.0%)0.762Drinking4 (11.4%)1 (6.7%)3 (15.0%)0.619Hypertension17 (48.6%)6 (40.0%)11 (55.0%)0.380Diabetes10 (28.6%)5 (33.3%)5 (25.0%)0.712Coronary heart disease3 (8.6%)1 (6.7%)2 (10.0%)1.000Atrial fibrillation5 (14.3%)3 (20.0%)2 (10.0%)0.631Previous stroke7 (20.0%)3 (20.0%)4 (20.0%)1.000Etiology of stroke0.771Large artery atherosclerotic18 (51.4%)7 (46.7%)11 (55.0%)Cardiac embolism14 (40.0%)7 (46.7%)7 (35.0%)Other or unknown3 (8.6%)1 (6.6%)2 (10.0%)MT strategy0.276Aspiration10 (28.6%)6 (40.0%)4 (20.0%)Aspiration + stent retriever25 (71.4%)9 (60.0%)16 (80.0%)Intravenous thrombolysis12 (34.3%)4 (26.7)8 (42.1)0.350Time from onset to puncture330.0 (271.3, 454.0)330.0 (255.0, 437.0)330.0 (275.0, 505.0)0.837Time from door to puncture42.0 (26.0, 53.0)32.0 (22.0, 44.0)46.0 (32.0, 80.0)0.039Time from puncture to reperfusion135.0 (95.0. 210.0)165.0 (100.0, 205.0)125.0 (65.0, 210.0)0.151Baseline NIHSS score18.5 (6.8, 32.8)24.5 (6.5, 32.8)18.0 (8.0, 35.0)0.821NIHSS score at 24 h16.0 (3.5, 25.0)9.0 (2.0, 33.5)17.0 (7.0, 24.0)0.957Data are n (%) or median (P25, P75); NIHSS, National Institutes of Health Stroke Scale. Table 1Comparison of baseline characteristics between groups.All (n = 35)Tortuous group (n = 15)non-Tortuous group (n = 20) P Age, years65.0 (52.0, 70.0)68.0 (57.0, 74.0)63.0 (47.0, 67.0)0.067Men21 (60.0%)7 (46.7%)14 (70.0%)0.163Smoking13 (37.1%)6 (40.0%)7 (35.0%)0.762Drinking4 (11.4%)1 (6.7%)3 (15.0%)0.619Hypertension17 (48.6%)6 (40.0%)11 (55.0%)0.380Diabetes10 (28.6%)5 (33.3%)5 (25.0%)0.712Coronary heart disease3 (8.6%)1 (6.7%)2 (10.0%)1.000Atrial fibrillation5 (14.3%)3 (20.0%)2 (10.0%)0.631Previous stroke7 (20.0%)3 (20.0%)4 (20.0%)1.000Etiology of stroke0.771Large artery atherosclerotic18 (51.4%)7 (46.7%)11 (55.0%)Cardiac embolism14 (40.0%)7 (46.7%)7 (35.0%)Other or unknown3 (8.6%)1 (6.6%)2 (10.0%)MT strategy0.276Aspiration10 (28.6%)6 (40.0%)4 (20.0%)Aspiration + stent retriever25 (71.4%)9 (60.0%)16 (80.0%)Intravenous thrombolysis12 (34.3%)4 (26.7)8 (42.1)0.350Time from onset to puncture330.0 (271.3, 454.0)330.0 (255.0, 437.0)330.0 (275.0, 505.0)0.837Time from door to puncture42.0 (26.0, 53.0)32.0 (22.0, 44.0)46.0 (32.0, 80.0)0.039Time from puncture to reperfusion135.0 (95.0. 210.0)165.0 (100.0, 205.0)125.0 (65.0, 210.0)0.151Baseline NIHSS score18.5 (6.8, 32.8)24.5 (6.5, 32.8)18.0 (8.0, 35.0)0.821NIHSS score at 24 h16.0 (3.5, 25.0)9.0 (2.0, 33.5)17.0 (7.0, 24.0)0.957Data are n (%) or median (P25, P75); NIHSS, National Institutes of Health Stroke Scale. Comparison of baseline characteristics between groups. Data are n (%) or median (P25, P75); NIHSS, National Institutes of Health Stroke Scale. Comparison of outcomes between groups Table 2 shows the rate of favorable outcomes in the tortuous group was significantly lower than that in the non-tortuous group (20% vs. 57.9%), and the difference was statistically significant after adjustment for age, baseline NIHSS score, and the time from groin puncture to reperfusion (P = 0.034). The rates of successful recanalization, poor outcomes, and neurological improvement at 7 days did not reach statistical significance. The rate of symptomatic ICH was higher in the tortuous group than in the non-tortuous group (26.7% vs. 15.8%), although not significantly. Figure 3 shows the overall distribution of the mRS scores at 90 days in the tortuous and non-tortuous groups. Table 2Comparison of outcomes between groups.Tortuous group (n = 15)non-Tortuous group (n = 20)UnadjustedAdjustedOR (95% CI) P OR (95% CI) P mTICI score 2b/312 (80.0)14 (73.7)1.429 (0.281–7.261)0.6671.014 (0.166–6.202)0.988Favorable outcome3 (20.0)11 (57.9)0.182 (0.038–0.864)0.0320.106 (0.013–0.846)0.034Poor outcome8 (53.3)6 (31.6)2.476 (0.610–10.058)0.2052.461 (0.489–12.392)0.275Neurological improvement at 7 d5 (33.3)7(36.8)1.167 (0.282–4.835)0.8320.603 (0.094–3.854)0.593Symptomatic ICH within 24 h4 (26.7)3 (15.8)1.939 (0.361–10.430)0.4401.344 (0.187–9.678)0.769mTICI, modified thrombolysis in cerebral infarction scale; NIHSS, National Institutes of Health Stroke Scale; ICH, intracranial hemorrhage; Adjusted for age, baseline NIHSS score, and time from puncture to reperfusion. Table 2Comparison of outcomes between groups.Tortuous group (n = 15)non-Tortuous group (n = 20)UnadjustedAdjustedOR (95% CI) P OR (95% CI) P mTICI score 2b/312 (80.0)14 (73.7)1.429 (0.281–7.261)0.6671.014 (0.166–6.202)0.988Favorable outcome3 (20.0)11 (57.9)0.182 (0.038–0.864)0.0320.106 (0.013–0.846)0.034Poor outcome8 (53.3)6 (31.6)2.476 (0.610–10.058)0.2052.461 (0.489–12.392)0.275Neurological improvement at 7 d5 (33.3)7(36.8)1.167 (0.282–4.835)0.8320.603 (0.094–3.854)0.593Symptomatic ICH within 24 h4 (26.7)3 (15.8)1.939 (0.361–10.430)0.4401.344 (0.187–9.678)0.769mTICI, modified thrombolysis in cerebral infarction scale; NIHSS, National Institutes of Health Stroke Scale; ICH, intracranial hemorrhage; Adjusted for age, baseline NIHSS score, and time from puncture to reperfusion. Comparison of outcomes between groups. mTICI, modified thrombolysis in cerebral infarction scale; NIHSS, National Institutes of Health Stroke Scale; ICH, intracranial hemorrhage; Adjusted for age, baseline NIHSS score, and time from puncture to reperfusion. Fig. 3Functional outcomes in the tortuous and the non-tortuous groups at 90 days. Functional outcome was evaluated by mRS score at 90 days post-operation. Score range: 0–6, with the higher score indicating greater disability; 0 indicating no symptoms at all, and 6 indicating death. mRS, modified Rankin scale. Functional outcomes in the tortuous and the non-tortuous groups at 90 days. Functional outcome was evaluated by mRS score at 90 days post-operation. Score range: 0–6, with the higher score indicating greater disability; 0 indicating no symptoms at all, and 6 indicating death. mRS, modified Rankin scale. Discussion Hitherto, only a few studies have reported data on the impact of tortuosity of the V1-segment VA on MT outcomes in patients with AVBAO. The main finding of this study was that the rate of favorable outcome at 90 days was significantly lower in patients with than without coiled or kinked V1-segment VA (P = 0.034). The tortuous group had a higher incidence of symptomatic ICH than the non-tortuous group (26.7% vs. 15.8%). The rate of successful reperfusion did not differ between the groups. In the present study, none of the baseline characteristics showed statistical differences, except for the time from admission to groin puncture. Notably, the age and female proportion of patients in the tortuous group were higher than those in the non-tortuous group, which is consistent with previous studies19. Also, the stroke severity was higher in the tortuous group than in the non-tortuous group (baseline NIHSS score of 24.5 vs. 18), which might be due to the older age and multiple comorbidities. The groin puncture to reperfusion time was longer in the tortuous group than in the non-tortuous group (165 min vs. 125 min), which was considered to be one of the factors leading to poor outcomes16. This was consistent with previous study, Ryu11 et al. suggested that VA tortuosity was increased with age and initial stroke severity and was associated with longer surgical time. In addition, the shorter time from admission to groin puncture (32 min vs. 46 min) in the tortuous group might reduce the difference in the clinical outcomes between the groups. The difference in clinical outcomes between groups may be the result of the combined effect of clinical characteristics. In the present study, a large difference was detected quantitatively in some baseline parameters between groups, but it did not reach statistical significance, which was related to the small sample size. The overall recanalization rate in this study was 74.3%, which was close to 71% in the BEST2 study but lower than 93% in the ATTENTION20 study. We noted that the proportion of LAA-related occlusion in the BEST study was 56%, 48 in the ATTENTION study, and 51.5% in this study. The difference in recanalization rate may be related to the pathogenic mechanism. Some studies have suggested that the low recanalization rate of LAA-related occlusion may be related to residual stenosis and the formation of reocclusion21. In addition, in order to highlight the effect of V1 segment tortuosity on MT, this study designed more stringent exclusion criteria, which may lead to a lower recanalization rate. Furthermore, the rates of successful reperfusion were similar between groups (80% vs. 73.3%, P = 0.998), but the rate of favorable outcomes of the tortuous group was significantly lower than that of the non-tortuous group, which may be related to futile recanalization after MT. Futile recanalization refers to the failure of patients to achieve functional independence at 90 days after MT (mRS score > 2) despite successful recanalization of occluded vessels on imaging (mTICI 2b/3).22 RESCUE-RE6 showed that the rate of futile recanalization after MT in patients with acute ischemic stroke was up to 49%. BEST2 showed that 46% of patients with AVBAO, who received EVT within 8 h after symptom onset, underwent futile recanalization. ANGEL-ACT23 is a real-world study comparing the safety and efficacy of MT vs. combined IVT and MT, suggesting that futile recanalization after MT was associated with advanced age, high baseline NIHSS score, and prolonged recanalization time. In this study, the overall rate of futile recanalization was 57.7% (15/26): 66.7% (8/12) in the tortuous group and 50% (7/14) in the non-tortuous group. The high rate of futile recanalization in the tortuous group may be related to older age, high baseline NIHSS scores, and prolonged recanalization time. Interestingly, although the NIHSS scores of the two groups at 24 h after MT were not statistically significant, the tortuosity group had a lower score. This may be a coincidence, and the small sample size led to the unstable statistical results. With the improvement in devices, we might be able to successfully navigate tortuous vessels and establish a stable thrombectomy path in most cases, potentially at the expense of prolonged recanalization time. Another previous study has shown that extracranial internal carotid artery (ICA) tortuosity is not correlated to the number of thrombectomies and successful recanalization but is correlated with neurological improvement24. Similar conclusions were reached in this study, the rates of successful recanalization were similar between groups, but the rate of favorable outcomes at 90 days in the tortuous group was significantly lower than that in the non-tortuous group. This phenomenon indicated that further shortening the time from onset to recanalization may be crucial to improving the outcomes of patients with AVBAO. Previous studies have shown that aspiration catheters and stent retrievers damage the intima and artery walls25. Excessive tortuous vessels increase the difficulty of the intravascular operation and passage times, as well as the risk of vascular injury. In addition, excessive tortuous vessels prolong the operation time and the recovery time of cerebral blood perfusion, which further aggravates the damage to the blood-brain-barrier. It is prone to reperfusion injury following successful recanalization, which increases the risk of symptomatic ICH26. The present study showed that there was no significant difference in the incidence of symptomatic ICH between groups. A recent study from Japan demonstrated that although ICA tortuosity was associated with ICH after MT, it was not associated with symptomatic ICH16. This negative result could be attributed to the small sample size of symptomatic ICH. Currently, only 7 cases of symptomatic ICH have been reported in the present study, and only 14 were included in the Japanese study. How to improve the favorable outcomes of patients with VA tortuosity after MT is challenging in clinical practice, and only a few studies have addressed this concern. When the aspiration catheter or stent retriever is pulled back, excessive tortuous vessels lead to the deformation or even collapse of the thrombectomy device, thus weakening the combination power between the device and thrombus, resulting in the rupture and escape of thrombus and even failure of MT16. In the future, how to overcome the adverse effects of vascular tortuosity on MT might become an effective means to improve the outcomes of patients. Notably, the vascular tortuosity can be straightened out by stenting or surgery;27 on the other hand, the design of thrombectomy devices should be updated to improve the performance to adapt to different vascular anatomy28. Nevertheless, the present study has several limitations. First, this was a single-center retrospective study, and the inherent bias could not be avoided. Second, to avoid the influence of device updates on the results, the time span of the cases included in this study was short; hence, the sample size was small, which may lead to the instability of the results. Third, tortuosity in other relevant vessels, especially V3-segment VA was not assessed. The unevaluated confounding factors may affect the results. Thus, large-scale clinical trials are needed to study the effect of VA tortuosity on MT in the future. Conclusions The tortuosity of V1-segment VA was independently associated with a lower rate of favorable outcome at 90 days following MT. The tortuosity of V1-segment VA had no significant effect on successful reperfusion and symptomatic ICH. Improving device performance to accommodate the tortuous vessels or straightening out the tortuous vascular anatomy may be an effective tool to improve the outcomes of MT.